Dialogue Health Technologies Inc.
DLHTF · OTC
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 4.1% | 23.9% | -16.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 59.7% | 57.4% | 54.7% | 52.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -15.7% | -7.6% | -9.3% | -23.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -22.5% | -10.8% | -22.8% | -25.4% |
| EPS Diluted | -0.086 | -0.04 | -0.068 | -0.091 |
| % Growth | -115.6% | 41.3% | 25.1% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | $0 | -$0 |